-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Ionis Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $64K, a 99.2% decline year-over-year.
- Ionis Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $13.2M, a 52% decline year-over-year.
- Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $32.3M, a 175% increase from 2022.
- Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $11.7M.
- Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$551K, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)